NanO2 in Large VessEL Occlusion Stroke (NOVEL)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Stroke Acute

Interventions

DRUG

NanO2TM

Intravenous NanO2 0.17ml/kg (three doses given over 4.5 hours)

OTHER

Sodium Chloride 0.9% Intravenous

Placebo

Trial Locations (1)

NHS Greater Glasgow and Clyde, Glasgow

All Listed Sponsors

collaborator

University of Glasgow

OTHER

collaborator

NuvOx LLC

INDUSTRY

lead

NHS Greater Glasgow and Clyde

OTHER